Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-4-27
pubmed:abstractText
Menstrual toxic shock syndrome is a rare but potentially life-threatening illness manifest through the actions of Staphylococcus aureus toxic shock syndrome toxin 1 (TSST-1). Previous studies have shown that tampon additives can influence staphylococcal TSST-1 production. We report here on the TSST-1-suppressing activity of 34 compounds that are commonly used additives in the pharmaceutical, food, and perfume industries. Many of the tested chemicals had a minimal impact on the growth of S. aureus and yet were potent inhibitors of TSST-1 production. The TSST-1-reducing compounds included surfactants with an ether, amide, or amine linkage to their fatty acid moiety (e.g., myreth-3-myristate, Laureth-3, disodium lauroamphodiacetate, disodium lauramido monoethanolamido, sodium lauriminodipropionic acid, and triethanolamine laureth sulfate); aromatic compounds (e.g. phenylethyl and benzyl alcohols); and several isoprenoids and related compounds (e.g., terpineol and menthol). The membrane-targeting and -altering effects of the TSST-1-suppressing compounds led us to assess the activity of molecules that are known to inhibit fatty acid biosynthesis (e.g., cerulenin, triclosan, and hexachlorophene). These compounds also reduced S. aureus TSST-1 production. This study suggests that more additives than previously recognized inhibit the production of TSST-1.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-10762277, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-11050088, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-11418146, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-15774886, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-15793101, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-16151216, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-1622174, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-16475828, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-2578120, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-2928637, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-3435143, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-4597730, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-49194, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-5335963, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-6340956, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-6436761, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-6827140, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-7432402, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-8021206, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-879741, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-907913, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223628-9422612
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1098-6596
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1898-906
pubmed:dateRevised
2010-9-22
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
pubmed:affiliation
University of Wisconsin-Madison, Department of Medical Microbiology and Immunology, 1550 Linden Dr., Madison, WI 53706, USA. pjmcnamara@wisc.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't